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Lymphocyte  egress  from  LNs  into  lymph 
requires  lymphocyte-intrinsic  sphingosine-1-
phosphate receptor 1 (S1P1), a G protein–cou-
pled receptor (Matloubian et al., 2004). S1P1 
promotes migration into exit structures, the 
lymphatic vessel endothelial hyaluronan recep-
tor 1+ (LYVE-1+) cortical sinuses of the LNs, 
within which lymphocytes may be captured by 
lymphatic flow and transported to the efferent 
lymph  (Pham  et  al.,  2008;  Grigorova  et  al., 
2009; Sinha et al., 2009). S1P is normally low 
in the lymphoid tissue and abundant in blood 
and lymph, and disruption of this S1P gradient 
results in an egress block (Schwab et al., 2005; 
Pappu et al., 2007). However, despite its impor-
tance for lymphocyte egress, the cellular source 
of lymph S1P remains unknown (Schwab and 
Cyster, 2007).
S1P production is dependent on sphingo-
sine kinase (Sphk) 1 and 2, enzymes that are ex-
pressed in most eukaryotic cell types (Kono 
et  al., 2008). Recent work has demonstrated 
that red blood cells are a major source of plasma 
S1P, whereas all lymph S1P and 5% of plasma 
S1P are supplied by a distinct, radiation-resistant 
source (Pappu et al., 2007). In vitro studies have 
shown that blood endothelial cells (BECs) can 
act as a source of S1P (Venkataraman et al., 2008). 
However, it has not been determined whether 
endothelial cells are an important source of S1P 
in vivo.
Lymphatic endothelial cells (LECs) arise from 
the venous endothelium during embryonic de-
velopment at around embryonic day (E) 9–9.5, 
when a subpopulation of endothelial cells of 
the anterior cardinal vein commit to the lym-
phatic lineage by turning on Prox1 expression 
(Karpanen and Alitalo, 2008). LYVE-1 is the 
earliest expressing and one of the most specific 
and widely used markers for LECs (Karpanen 
and Alitalo, 2008; Oliver and Srinivasan, 2008).
Mice lacking Sphk1 and Sphk2 die in utero 
between E11.5–13.5 because of blood vascular 
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Lymphocyte egress from lymph nodes (LNs) is dependent on sphingosine-1-phosphate 
(S1P), but the cellular source of this S1P is not defined. We generated mice that expressed 
Cre from the lymphatic vessel endothelial hyaluronan receptor 1 (Lyve-1) locus and that 
showed efficient recombination of loxP-flanked genes in lymphatic endothelium. We report 
that mice with Lyve-1 CRE-mediated ablation of sphingosine kinase (Sphk) 1 and lacking 
Sphk2 have a loss of S1P in lymph while maintaining normal plasma S1P. In Lyve-1 Cre+ 
Sphk-deficient mice, lymphocyte egress from LNs and Peyer’s patches is blocked. Treatment 
with pertussis toxin to overcome Gi-mediated retention signals restores lymphocyte 
egress. Furthermore, in the absence of lymphatic Sphks, the initial lymphatic vessels in 
nonlymphoid tissues show an irregular morphology and a less organized vascular endothelial 
cadherin distribution at cell–cell junctions. Our data provide evidence that lymphatic 
endothelial cells are an in vivo source of S1P required for lymphocyte egress from LNs and 
Peyer’s patches, and suggest a role for S1P in lymphatic vessel maturation.
© 2010 Pham et al.  This article is distributed under the terms of an Attri-
bution–Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first  six 
months after the publication date (see http://www.jem.org/misc/terms.shtml). 
After six months it is available under a Creative Commons License (Attribu-
tion–Noncommercial–Share Alike 3.0 Unported license, as described at http://
creativecommons.org/licenses/by-nc-sa/3.0/).
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YFP expression (Fig. 1 C). YFP was variably observed in non–
LYVE-1+ endothelial cells, as well as some other cells that are 
likely radiation-resistant lymphocytes. YFP was also observed 
in LYVE-1+ lymphatic vessels in the ear dermis and small 
intestine (Fig. S2, A and B). Collectively, these findings indi-
cate the Lyve-1 Cre+ mice exhibit efficient recombination of 
a floxed gene element in LYVE-1+ cells within lymphoid and 
nonlymphoid tissues.
S1P metabolic enzyme expression by LECs
By quantitative PCR analysis we detected selective expression 
of Lyve-1 and Prox1 in the isolated LN LEC population, con-
firming their lymphatic identity (Fig. 1 D). LECs expressed 
Sphk1 and Sphk2 abundantly compared with spleen cells (Fig. 
1 D). Reciprocally, analysis of enzymes that degrade S1P revealed 
that LECs have a lower abundance of transcripts for S1P lyase, 
lipid phosphate phosphatase 3, and S1P-phosphatase 1 than 
one  or  more  of  the  other  cell  types  analyzed  (Fig.  1  D).   
Recently, SPNS2 was implicated as an S1P transporter in ze-
brafish (Osborne et al., 2008; Kawahara et al., 2009). Tran-
scripts for the mouse SPNS2 orthologue were abundantly 
expressed in LECs (Fig. 1 D). Thus, LN LECs have a tran-
scriptional profile consistent with their functioning as a source 
of extracellular S1P.
Ablation of lymph S1P by conditional deletion of Sphk1  
in Sphk2 null mice
To test the role of LYVE-1+ cells in generating lymph S1P, we 
intercrossed Lyve-1 Cre+ mice with animals carrying floxed 
and null alleles of Sphk1 and null alleles of Sphk2. Flow cyto-
metric analysis of lymphocytes in the lymph of Lyve-1 Cre+ 
Sphk1f/ or f/f Sphk2/ mice showed high surface S1P1 as 
compared with controls, which had undetectable amounts of 
receptor (Fig. 2 A). Lymphocyte S1P1 is very sensitive to S1P-
induced down-modulation, and 1 nM S1P down-modulates 
S1P1 on mature thymocytes (Schwab et al., 2005). Thus, the 
high surface S1P1 on lymphocytes in the lymph suggested a 
marked reduction from the normal 100–300-nM lymph S1P 
concentration (Pappu et al., 2007). In contrast, lymphocytes 
from the blood of lymphatic Sphk-deficient and control mice 
both had undetectable surface S1P1 (Fig. 2 A), consistent 
with blood S1P being maintained mostly by red blood cells 
(Pappu et al., 2007). Using a sensitive S1P bioassay in which 
S1P concentration is measured by the extent of Flag-tagged 
S1P1  receptor  down-modulation  in  a  cell  line  (Schwab   
et al., 2005; Pappu et al., 2007), the lymphatic Sphk-deficient 
mice had undetectable amounts of S1P in lymph, indicat-
ing that levels were at least 50-fold lower than in control 
mice  (Fig.  2  B). There  was  no  difference  in  blood  S1P 
abundance between lymphatic Sphk-deficient and control 
mice (Fig. 2 B).
LYVE-1–expressing macrophages are not a significant 
source of lymph S1P
Besides LECs, a subset of macrophages has been suggested to 
express LYVE-1 (Jackson, 2004). To determine the radiation 
defects (Mizugishi et al., 2005). In vitro, stimulation of BECs 
with S1P increases localization of vascular endothelial cadherin 
(VE-cadherin) at cell–cell junctions and induces tubular mor-
phogenesis (Lee et al., 1999). Recently, S1P was demonstrated 
to promote tubular formation of human dermal LECs in vitro 
and lymphangiogenesis in Matrigel in vivo (Yoon et al., 2008). 
However, whether S1P signaling normally plays a role in the 
development of the lymphatic system is not known.
In this report, by examining mice that lack Sphk2 and 
have Sphk1 conditionally deleted by a CRE recombinase 
expressed from the Lyve-1 locus, we provide evidence that 
LECs are the major source of lymph S1P. Lymphatic Sphk-
deficient mice experienced a block of T and B cell egress 
from LNs. Additionally, lymphatic Sphk-deficient mice dis-
played altered initial lymphatic vessel morphology and junc-
tional VE-cadherin patterning in the trachea and diaphragm.
RESULTS AND DISCUSSION
Specificity of Lyve-1 CRE-mediated gene deletion
To achieve ablation of loxP-flanked genes in LECs, we gener-
ated a knockin mouse line in which an EGFP-hCre transgene 
preceded by an internal ribosomal entry site was inserted into the 
3 untranslated region of the Lyve-1 gene (Fig. S1, A and B). Im-
munofluoresence analysis of tissue from Lyve-1 EGFP-hCre+ mice 
showed selective GFP staining in the nuclei of LYVE-1+ cells 
(Fig. S1 C). In the absence of antibody staining, however, the 
eGFP fluorescence was not readily detected, and for simplicity 
we refer to the knockin mice as Lyve-1 Cre+ mice. To deter-
mine the efficiency and specificity of Lyve-1 Cre-mediated gene 
deletion, Lyve-1 Cre+ mice were intercrossed to mice carrying 
YFP preceded by a floxed transcriptional stop in the Rosa26 locus 
(Srinivas et al., 2001). Activation of reporter expression was exam-
ined in LNs. By flow cytometric analysis, we identified LN LECs 
as CD45 CD31hi gp38 (podoplanin)hi cells (Fig. 1 A; Link et al., 
2007). To confirm the identity of these cells as LECs, we further 
demonstrated that they express high amounts of surface LYVE-
1 (Fig. 1 A) as compared with CD45 CD31hi gp38lo BECs, 
CD45 CD31lo gp38hi fibroblastic reticular cells (FRCs), and 
other CD45 LN stromal cells. When analyzed for reporter ex-
pression, >90% of LECs were YFP+ (Fig. 1 B), indicating efficient 
CRE-mediated gene deletion in these cells. A varying fraction of 
BECs was also positive for YFP reporter expression, probably be-
cause of the differential expression of LYVE-1 in subsets of BECs 
that has been observed during embryonic development (Gordon 
et al., 2008). In contrast, few FRCs were YFP+. We also ob-
served that a fraction of CD45+ cells (42.4 ± 6.8%), including 
lymphocytes (41.8 ± 5.8%) and myeloid cells (42.9 ± 2.4%), were 
YFP+, suggesting that there is some Cre activity in hematopoietic 
precursor cells. It will be valuable in future studies to examine 
hematopoietic precursors for LYVE-1 expression.
Immunofluorescence analysis of LN tissues obtained from 
Lyve-1 Cre+ YFP reporter mice that had been lethally irradi-
ated and reconstituted with wild-type BM showed extensive 
overlap between YFP and LYVE-1 immunoreactivity (Fig. 1 C). 
In particular, the cells lining cortical sinusoids, identified by 
their LYVE-1 staining and location in the T cell zone, showed JEM VOL. 207, January 18, 2010  19
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et al., 2008), CD11bhi CD11cmed and CD11bhi CD11clo cell 
subsets were found to express LYVE-1 (Fig. 3, A and B). 
Importantly, these LYVE-1+ macrophage subsets exhibited 
>85% chimerism (Fig. 3 C). There was similarly high re-
placement of all the myeloid cell subsets (Fig. 3 C) as well as 
sensitivity of LYVE-1+ LN macrophages and test if they 
made a contribution to lymph S1P, we performed BM chimera 
studies,  reconstituting  CD45.2+  lymphatic  Sphk-deficient 
mice with CD45.1+ wild-type BM. Using a gating scheme 
previously used to identify LN macrophage subsets (Jakubzick 
Figure 1.  Efficiency of Lyve-1 CRE-mediated gene deletion and S1P metabolic enzyme expression in LECs. (A) Isolation and identification of LECs. 
LNs were minced and digested as detailed in Materials and methods. CD31 and gp38 expression allows separation of LECs from other CD45 cells: FRCs, BECs, 
and double-negative stromal cells (Others). (left plot) LYVE-1 on indicated populations; (right plots) Control stains for each cell type. (B) Flow cytometric analy-
sis of YFP in cells isolated from LNs of Lyve-1 Cre+ Rosa26-YFP reporter mice (percentages are shown). The four cell populations are gated according to the 
scheme in A. Peripheral LNs (pLN; axillary, brachial, and inguinal nodes) and mesenteric LNs (mLN) are shown. The shaded histogram represents Cre-negative 
cells. (C) Immunofluorescence analysis of YFP in LNs of Lyve-1 Cre+ or Rosa26-YFP mice that had been reconstituted with wild-type BM. Fixed LN sections 
were stained as indicated. Data in A–C are representative of at least three experiments with one to two mice of each type per experiment. (D) Quantitative 
RT-PCR analysis of S1P metabolic genes in cells sorted from a pool of peripheral and mesenteric LNs using the scheme in A and from spleen tissue or splenic  
B cells. Data are representative of three separate sorts with 10–15 mice in each sort, with each gene expression measured at least twice. Bars represent means.20 Lymphatic S1P promotes egress | Pham et al.
patches of lymphatic Sphk-deficient mice as compared with 
the increase exhibited in the LNs, suggesting a more complete 
loss of S1P availability in the Peyer’s patches (Fig. 4 F). The 
reduced T cell numbers in LNs cannot be adequately ac-
counted for by the accumulation in Peyer’s patches, and we 
did not find an accumulation of T cells in the liver or lung 
(Fig. S2 D). The reduction in LN T cells may reflect a require-
ment for T cells to recirculate between lymphoid tissues (Link 
et al., 2007), or possibly a more direct effect of S1P on T cells 
or the LN microenvironment that promotes T cell survival 
(Kennedy et al., 2009).
Consistent with the reduced lymphocyte numbers in the 
lymph,  LYVE-1+  sinuses  in  lymphatic Sphk-deficient  LNs 
contained  almost  no  lymphocytes  and  appeared  collapsed 
(Fig. 4 G). In contrast, LYVE-1+ sinuses in control LNs were 
extended with cells (Fig. 4 G). A similar emptying of cortical 
sinuses was seen 6 h after treatment of wild-type mice with 
the  S1P1-modulating  and  egress-inhibiting  drug  FTY720 
(Rosen and Goetzl, 2005; Schwab and Cyster, 2007), indicat-
ing that sinus emptying can occur rapidly and need not reflect 
a developmental abnormality (Fig. S2 E). Lymphatic Sphk-
deficient animals also showed a deficiency of lymphocytes in 
intestinal lymphatic sinuses adjacent to and likely draining 
from (Azzali, 2003) Peyer’s patches (Fig. 4 H). These findings 
provide evidence for the involvement of lymphatic-derived 
S1P in the earliest step of lymphocyte egress from LNs and 
Peyer’s patches.
lymphocytes (not depicted). In these BM chimeras, lymph 
S1P was reduced to the same extent observed in nonchimeric 
Sphk-deficient animals, as indicated by the presence of surface 
S1P1 on T cells in the lymph (Fig. 3 D) and by S1P bioassay 
(Fig. 3 E). These experiments suggest that hematopoietic 
cells within LNs, including the LYVE-1–expressing macro-
phage subpopulations, do not make a significant contribution 
to lymph S1P.
Impaired lymphocyte egress in lymphatic Sphk-deficient mice
Flow cytometric analysis of lymph isolated from the cysterna 
chyli of lymphatic Sphk-deficient mice revealed that T and B 
lymphocyte numbers were markedly reduced, in some cases 
up to 50-fold (Fig. 4 A), indicating that egress from LNs was 
strongly reduced. We detected a similar extent of egress 
impairment in lymphatic Sphk-deficient mice that had been 
reconstituted with wild-type BM (Fig. S2 C). There was also 
a decrease in lymphocyte numbers in the circulation and the 
spleen (Fig. 4, B and C). Because blood S1P levels were 
normal in lymphatic Sphk-deficient mice, lymphocytes pre-
sumably could egress from the spleen and traffic to the LNs, 
where their egress is impaired. Interestingly, we did not ob-
serve an expansion of the lymphocyte compartment in the 
LNs but saw a consistent reduction of T cell numbers (Fig. 4 D). 
Concomitantly, there was an accumulation of naive T cells in 
the Peyer’s patches (Fig. 4 E). We observed a larger increase 
of surface S1P1 on naive T cells recovered from Peyer’s 
Figure 2.  Ablation of lymph S1P by conditional deletion of Sphk1 in Sphk2-deficient mice. (A) Flow cytometric analysis showing S1P1 on CD4+ 
CD62Lhi T cells from the indicated circulatory fluids and tissues.  indicates Lyve-1 Cre+ Sphk1f/ or f/f Sphk2/ mice; C indicates littermate control. The 
shaded histograms show staining with control antibody of cells from LN and blood. Bld, blood; Lym, lymph; Spl, spleen. (B) Measurement of S1P level by 
bioassay. Lymph fluid and plasma samples were prepared (see Materials and methods) and titrated onto WEHI231 cells expressing FLAG-S1P1. The x axis 
shows dilution of the samples. The y axis indicates mean fluorescence intensity (MFI) of FLAG antibody staining. Data are representative of at least five 
experiments with one to two mice each.JEM VOL. 207, January 18, 2010  21
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treated T cells in lymph was about one third the frequency of 
OB-treated cells in the control hosts, their frequency was up 
to eightfold higher than that of OB-treated cells in the lymph 
of lymphatic Sphk-deficient hosts (Fig. 5, A and B). These 
data suggest that although egress of control (OB)-treated T 
cells was blocked in lymphatic Sphk-deficient animals, PTX-
treated cells continued to exit into the lymph. Moreover, the 
appearance  of  cotransferred  PTX-treated  but  not  control 
cells in the lymph also makes it unlikely that the marked re-
duction in control cells in the lymph is caused by a loss of 
lymph flow through the LN. When absolute cell numbers 
were  plotted,  there  was  no  difference  in  the  numbers  of 
PTX-treated T cells in lymph of control and lymphatic Sphk-
deficient recipients, suggesting that these cells can undergo 
egress to a similar extent in both types of hosts (Fig. 5 C). 
PTX treatment also partially restored B cell egress in host 
Restoration of egress in lymphatic S1P-deficient mice  
by pertussis toxin (PTX) treatment
When Gi-mediated retention signals are blocked, the lym-
phocyte-intrinsic requirement for S1P1 during LN egress is 
partially overcome (Pham et al., 2008). To test whether the 
lymphocyte egress defect in Lyve-1 Cre+ Sphk-deficient mice 
occurs via effects on the lymphocytes, we sought to deter-
mine if inhibition of Gi-mediated retention signaling would 
restore egress. Wild-type lymphocytes were treated ex vivo 
either  with  PTX  or  the  nonenzymatic  oligomer-B  (OB) 
subunit of PTX as a control using a pulse-loading procedure 
that allowed treated cells to continue entry into LNs for 2–3 
h after being transferred into recipient mice, before complete 
inhibition of Gi (Lo et al., 2005; Pham et al., 2008). After 1 
d of equilibration, the distribution of transferred cells in host 
animals was determined. Although the frequency of PTX-
Figure 3.  Lack of contribution of myeloid cells to lymph S1P. (A) Flow cytometric analysis of enzyme-digested LN cells to detect CD11b and CD11c.  
(B) LYVE-1 or control antibody staining of the six cell populations shown in A. (C) The proportion of each subpopulation replaced by donor-derived cells in lethally 
irradiated CD45.2+ Lyve-1 Cre+ Sphk-deficient mice reconstituted with wild-type CD45.1+ BM. Numbers refer to the percentage of cells in the indicated gates. 
(D) S1P1 on CD4+ CD62Lhi T cells from the lymph and LNs of mice that had been reconstituted with wild-type BM as in C. Sphk  indicates the Lyve-1 Cre+ 
Sphk-deficient host; C indicates the control host. The shaded histogram shows staining of LN cells from an FTY720-treated mouse. (E) Bioassay measurement 
of S1P in lymph and plasma from the chimeric mice. Data in A–E are representative of three experiments with three mice. MFI, mean fluorescence intensity.22 Lymphatic S1P promotes egress | Pham et al.
Altered lymphatic vasculature in lymphatic  
Sphk-deficient mice
Because of the established functions of S1P signaling in the 
development of the blood vasculature, we sought to deter-
mine if ablation of lymph S1P had an effect on lymphatic   
vasculature. Lymphatic vessel morphology and architecture 
in the trachea and diaphragm have been well studied (Baluk   
et al., 2007), and we therefore examined these tissues. When 
visualized by whole-mount staining for LYVE-1, the lym-
phatic vessels in the trachea of lymphatic Sphk-deficient   
animals deficient in lymph S1P (Fig. S3, A and B). By immu-
nohistochemical analysis, OB-treated T cells were found in 
the LYVE-1+ cortical sinuses of control but not lymphatic 
Sphk-deficient mice (Fig. 5 D and Fig. S3 C). In contrast, 
PTX-treated cells could be identified within the cortical si-
nuses  of  both  control  and  lymphatic  Sphk-deficient  mice 
(Fig. 5 D and Fig. S3 C). Collectively, these findings support 
the conclusion that LEC-derived S1P acts on lymphocytes to 
promote localization of cells within LYVE-1+ sinuses and 
egress from LNs.
Figure 4.  Impaired lymphocyte egress in Lyve-1 Cre Sphk-deficient mice. (A–E) Cell numbers in the indicated fluids and tissues in Lyve-1 Cre+ 
Sphk-deficient and control mice. The LN count was from a pool of two axillary, brachial, and inguinal LNs. Enumerated CD4+, CD8+, and CD19+ cells were 
CD62Lhi. Points indicate data from individual mice, and white (control mice) and black (Sphk-deficient mice) bars represent means. (F) S1P1 on CD4+ 
CD62Lhi T cells from the indicated tissues. Shaded histograms show staining with control antibody. The vertical dashed lines mark the peak S1P1  
intensity in the LN sample to allow comparison. Data in A–F are representative of at least three experiments with one to two mice per experiment.  
(G and H) Immunohistochemial analysis of LNs (G) and Peyer’s patches (H) stained for LYVE-1 (brown) and CD3 (blue) or B220 (blue).JEM VOL. 207, January 18, 2010  23
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that lymphatic S1P may help regulate this process under 
homeostatic conditions.
Early in vitro studies with BECs showed that S1P stimu-
lation increased VE-cadherin localization at cell–cell junctions 
and enhanced adherens-junction assembly (Lee et al., 1999). 
S1P signaling has also been implicated in promoting tight-
junction formation between BECs (Sanchez et al., 2003; Lee 
et al., 2006; Camerer et al., 2009), and N-cadherin–mediated 
adhesive interactions between BECs and mural cells (Paik et al., 
2004). Although in control mice the characteristic VE-cadherin+ 
mice appeared tortuous and ragged, with occasional sprouts, 
as compared with the smooth tubular structure of lym-
phatic vessels in the control mice (Fig. 6 A and Fig. S4 A).   
A  similarly  altered  morphology  was  noted  in  lymphatics 
within the diaphragm (Fig. S4 B), and in some cases LYVE-1   
staining intensity was reduced (Fig. S4, A and B). The 
increased number of “spikes” in the initial lymphatics of 
Lyve-1 Cre+ Sphk-deficient mice bears some resemblance 
to the lymphatic sprouting observed under conditions fa-
voring lymphangiogenesis (Baluk et al., 2005), suggesting 
Figure 5.  PTX treatment facilitates lymphocyte egress and localization in cortical sinuses in Lyve-1 Cre+ Sphk-deficient mice. (A–C) Spleno-
cytes were treated with either PTX or OB and cotransferred into recipient hosts. 22 h later, transferred cell numbers were determined in the lymph and 
LNs of Lyve-1 Cre+ Sphk-deficient (Sphk ) and control hosts. (A) Flow cytometric analysis of transferred T cells present in the lymph. PTX-treated cells 
were CFSE labeled. Numbers refer to the percentage of cells in the indicated gates. (B) Frequency of transferred OB (O)- and PTX (P)-treated cells in pe-
ripheral LNs (pLN), mesenteric LNs (mLN), and the lymph (Lym). (C) Total numbers of transferred CD4 and CD8 T cells in the lymph of control and Sphk-
deficient recipients from the same experiments as in B. In B and C, points indicate data from individual mice, and bars indicate means. (D) Distribution of 
transferred OB- and PTX-treated cells with respect to LN cortical sinuses. Purified T cells were treated and cotransferred into control or Sphk  hosts as in 
A–C. Sections were stained for LYVE-1 (brown) and transferred T cells (blue). Several transferred cells located within sinuses of the Sphk-deficient recipi-
ent are marked by arrows. Data in A–D are representative of at least three experiments with one to two mice per experiment. C, control; , Sphk deficient.24 Lymphatic S1P promotes egress | Pham et al.
(Baluk et al., 2005) of nonlymphoid tissue lymphatics (Fig. 
S4 E). In the lymphatic Sphk-deficient mice, although the 
LN LYVE-1+ sinuses often appeared collapsed, the VE-cad-
herin distribution appeared similar (Fig. S4 E). However, higher 
resolution approaches will be required to determine pre-
cisely how VE-cadherin is organized at LN cortical sinus cell 
junctions of wild-type and mutant mice.
To determine if the altered morphology of initial lym-
phatics in Lyve-1 Cre+ Sphk-deficient mice led to major defects 
in cell trafficking, we examined the numbers of tissue-derived 
DCs in skin-draining LNs. By gating on a population that 
contains the majority of the skin-derived DCs in the LNs 
(Jakubzick et al., 2008), we observed no apparent difference in 
the numbers of these cells in lymphatic Sphk-deficient and 
control mice under steady state (Fig. S4 F). In a second experi-
ment, BM-derived DCs were transferred subcutaneously to 
discontinuous junctions at the initial lymphatics were apparent 
and often consisted of a series of “buttons” (Baluk et al., 2005), 
the junctions in the affected animals were less defined, usually 
being made up by fewer or more diffuse buttons (Fig. 6, B   
and C; and Fig. S4 C). Consistent with previous studies (Yoon 
et al., 2008; Sinha et al., 2009), we found that LECs expressed 
S1p1, and to a lesser extent S1p3 (Fig. S4 D), suggesting that 
LECs are capable of transducing signals from extracellular S1P 
that mediate organization of lymphatic cell–cell junctions. Tak-
ing these findings together with earlier work, S1P may have 
similar actions on blood vessel and lymphatic endothelium, 
regulating the localization of cadherins at cell–cell junctions. 
LN LECs also express VE-cadherin (Pfeiffer et al., 2008), but its 
junctional distribution has not yet been well studied. In wild-
type LNs, we observed a VE-cadherin distribution in LYVE-1+ 
sinuses that was less well defined than the buttons and zippers 
Figure 6.  Lymphatic Sphk expression is required for normal lymphatic vessel maturation. (A) Confocal images showing lymphatic vessels stained 
with antibody against LYVE-1 in whole mount of mouse trachea. Arrowheads point to the jagged appearance of the lymphatic vessels in Lyve-1 Cre+  
Sphk-deficient mice. (B) Confocal images showing the button-like pattern of VE-cadherin at endothelial cell–cell junctions of the diaphragm initial lym-
phatics. Arrowheads mark VE-cadherin+ buttons in the control and a corresponding junctional region in the Lyve-1 Cre+ Sphk-deficient mice. White 
squares (top) indicate enlarged regions (bottom). Data are representative of six experiments (n = 6 mice). (C) VE-cadherin buttons per 1,000-µm2 projected 
area of lymphatic for littermate control and lymphatic Sphk-deficient trachea (n = 3 mice per group). Bars show means ± SE. *, P < 0.05 (Student’s t test).JEM VOL. 207, January 18, 2010  25
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two doses separated by 3 h and injected with 5 × 106 wild-type BM cells pre-
pared from a CD45.1+ donor. In some experiments, 2 × 107 cells/ml were 
labeled with 3.3 µM CFSE (Invitrogen) or 10 µM 5-(and-6)-(((4-chlorometh
yl)benzoyl)amino)tetramethylrhodamine  (CMTMR;  Invitrogen)  in  RPMI 
1640 containing 2% FCS for 20 min at 37°C, and were then washed by spin-
ning through a layer of FCS. Labeled cells were resuspended at 2 × 107 
cells/ml, and were treated with 10 ng/ml OB or PTX at 37°C for 10 min, 
washed twice in warm RPMI 1640 with 2% FCS and 10 mM Hepes, and 
transferred to recipient mice. Lymph collection was performed as previously 
described (Matloubian et al., 2004). In brief, under a stereomicroscope, lymph 
was drawn from the cysterna chyli using a fine borosilicate glass microcapillary 
pipette (Sutter Instrument Co.). Cell numbers determined by flow cytometry 
were divided by the volume of collected lymph to determine the concentra-
tion. Protocols were approved by the Institutional Animal Care and Use 
Committee of the University of California, San Francisco.
Isolation of LECs. LNs removed from mice were minced into small pieces 
and added into RPMI 1640 medium containing 2% FCS, 10 mM Hepes, 
100 µg/ml DNase, and 0.2 mg/ml Blendzyme 2 (Roche). The samples were 
incubated at 37°C for 25 min, rotating. Midway through the digestion, sam-
ples were passed through glass Pasteur pipettes multiple times to help break 
up the pieces of LNs. The digestion was stopped by addition of EDTA and 
FCS to a final concentration of 10 mM and 10%, respectively. The samples 
were filtered through 100-µM cell strainers and centrifuged at 450 g for 7 min. 
Cell pellets were resuspended in RPMI 1640 medium containing 2% FCS, 
10 mM Hepes, and 5 mM EDTA for analysis.
S1P bioassay. The assay was performed as described by Pappu et. al. (2007). 
In brief, platelet-poor plasma or cell-depleted lymph was titrated into RPMI 
1640 containing 10 mM Hepes and 0.5% fatty-acid free BSA (EMD) in a 
96-well U-bottom plate. 4 × 104 WEHI231 cells stably expressing FLAG-
tagged S1P1 (Lo et al., 2005) were added to each well, and the plate was 
incubated for 40 min at 37°C. Cells were analyzed by flow cytometry to 
measure the surface FLAG-S1P1 level using the M2-FLAG antibody (Sigma-
Aldrich). Lymph was drawn as described in Mice and adoptive cell transfer 
into Alsever solution, and cells were removed by centrifugation. Platelet-
poor plasma was prepared by centrifuging whole blood for 10 min at 630 g 
at room temperature.
Immunohistochemical and flow cytometric analysis. 7-µm cryostat 
sections were fixed and stained as previously described (Reif et al., 2002). 
CFSE-labeled cells were visualized in sections with alkaline phosphatase–
conjugated antifluorescein antibodies (Roche). Congenic transferred lympho-
cytes were visualized by staining with biotinylated antibodies to CD45.1 
(clone A20) or CD45.2 (clone 104). The LYVE-1–specific antibody Mab22 
was generated as previously described (Pham et al., 2008) and was from 
R&D Systems. The anti–mouse gp38 (podoplanin) hybridoma was from 
American Type Culture Collection. For visualization of LYVE-1+ structures 
in sections, either unconjugated or biotinylated Mab22 was used. Lympho-
cyte preparations were stained with various fluorochrome-conjugated anti-
bodies purchased from BD or anti-S1P1 as previously described (Lo et al., 
2005), and data were acquired on a FACS LSRII (BD) and analyzed with 
FlowJo software (Tree Star, Inc.).
Immunofluorescence analysis. 7-µm sections were prepared from para-
formaldehyde-fixed tissues, dried, and blocked with immunomix (1× PBS, 
5% normal serum, 0.3% Triton X-100, 0.2% BSA, and 0.1% sodium azide) 
for at least 1 h. Sections were stained with primary antibodies in immuno-
mix: biotinylated anti–LYVE-1 (R&D Systems) and rabbit anti-GFP (Invit-
rogen or Millipore) for 3 h to overnight. After two washes with 1× PBS, 
sections were stained with Cy3- and Cy5-conjugated antibodies (Jackson 
ImmunoResearch Laboratories, Inc.) and DAPI for 3 h. Sections were ana-
lyzed on a microscope (Axiovert Z1; Carl Zeiss, Inc.). For whole-mount 
staining, mice were perfused for 2 min with fixative (1% paraformaldehyde 
in PBS, pH 7.4) from a cannula inserted through the left ventricle into the 
aorta. The tracheas and diaphragms were removed and immersed in fixative 
Lyve-1 Cre+ Sphk-deficient and control mice. 2 d later, similar 
numbers of transferred DCs were recovered from the popliteal 
LNs of both types of mice (Fig. S4 G), suggesting that the 
afferent lymphatics of Lyve-1 Cre+ Sphk-deficient mice can 
support DC migration.
Concluding remarks
Using a genetic approach, we provide evidence in this report 
that LECs are the main source of S1P needed for lymphocyte 
egress from LNs and Peyer’s patches into lymph. The partial 
Lyve-1 Cre activity in BECs is considered unlikely to ac-
count for the reduction in lymph S1P because the amounts of 
S1P in blood were unaffected by Lyve-1 Cre-mediated Sphk1 
ablation. We also consider it unlikely that Lyve-1 Cre activity 
in hematopoietic cells is responsible, because the major he-
matopoietic cell populations were well replaced by wild-type 
cells in BM chimera experiments that showed no restoration 
in lymph S1P; involvement of some other cell type that was 
not tracked in our analysis and that had high Lyve-1 Cre 
activity and was not well replaced by irradiation and recon-
stitution with wild-type BM cannot be ruled out, but is con-
sidered the less likely explanation of our observations. The 
ability to restore measurable lymphocyte egress in lymphatic 
Sphk-deficient mice by antagonizing Gi-mediated retention 
provided evidence that the egress defect was caused by a re-
quirement for S1P to act on the lymphocytes rather than on 
endothelial egress barriers. These studies support a model in 
which S1P produced locally by LYVE-1+ cortical sinus lining 
cells is essential in promoting lymphocyte egress from LNs. 
In addition, lymphatic Sphk-deficient mice exhibit altered mor-
phology and junctional patterning in initial lymphatic vessels 
in nonlymphoid tissues, establishing a role for Sphk activity, 
and likely S1P, in maturation of these vessels. The similar lack of 
cortical sinus lymphocytes in LNs from Sphk-deficient mice 
and 6-h FTY720-treated mice, together with the PTX treat-
ment and DC migration data, suggests that the emptying of 
these sinuses is secondary to the block in lymphocyte egress 
rather than being a consequence of developmental abnormal-
ities. However, we do not rule out the possibility that cor-
tical sinus endothelial cell junctions are affected by Sphk 
deficiency. Finally, our findings suggest that perturbations 
altering S1P availability or S1P receptor function may lead to 
alterations  in  lymphatic  vessels,  and  further  work  will  be 
needed to define the extent to which such perturbations affect 
lymphatic function.
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mice were from the National Cancer Institute or a colony maintained at the 
University of California, San Francisco. Mice lacking Sphk2 and carrying 
LoxP-flanked Sphk1 were on a B6/129 mixed background (Pappu et al., 
2007). Lyve-1 Cre knockin mice on a B6/129 mixed background were gener-
ated as described in Fig. S1. Lyve-1 Cre+ Sphk1f/ or f/f Sphk2/ mice were 
generated by intercrossing. Control mice were usually littermates and were al-
ways from the same intercross and carried at least one wild-type Sphk allele. 
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